2020
Breadcrumbs:  homepage  Publications  2020


193H.Y. Wang, X.H. Zhang, Y. Zhang*, R. Cheng*, J.D. Yuan, and Z.Y. Zhong*, Systemic Delivery of NAC-1 siRNA by Neuropilin-Targeted Polymersomes Sensitizes Antiangiogenic Therapy of Metastatic Triple Negative Breast Cancer, Biomacromolecules 2020, 21, 5119-5127.193.pdf

192C. Gao, Q. Cheng, J.W. Wei, C. Sun, S.Y. Lu, C.H.T. Kwong, S.M.Y. Lee, Z.Y. Zhong*, and R.B. Wang*, Bioorthogonal supramolecular cell-conjugation for targeted hitchhiking drug delivery, Mater. Today 2020, 40, 9-17.192.pdf

191C. Deng*, Q. Zhang, J.Q. Guo, X.F. Zhao, and Z.Y. Zhong*, Robust and **art polypeptide-based nanomedicines for targeted tumor therapy, Adv. Drug Deliv. Rev. 2020, 160, 199-211. 191.pdf

190C.J. Zhang, X.X. Wang, R. Cheng*, and Z.Y. Zhong*, A6 Peptide-Tagged Core-Disulfide-Crosslinked Micelles for Targeted Delivery of Proteasome Inhibitor Carfilzomib to Multiple Myeloma in Vivo, Biomacromolecules 2020, 21, 2049-2059.190.pdf

189C. Zhou, Y.F. Xia, Y.H. Wei, L.Cheng*, J.J. Wei, B.B. Guo, F,H. Meng*, S.P. Cao, J.C.M. van Hest, and Z.Y. Zhong*, GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma, Acta Biomaterialia 2020, 113, 512-521.189.pdf

188H.L. Sun, and Z.Y. Zhong*, 100th Anniversary of Macromolecular Science Viewpoint: Biological Stimuli-Sensitive Polymer Prodrugs and Nanoparticles for Tumor-Specific Drug Delivery, ACS Macro Lett. 2020, 9, 1292-1302.188.pdf

187X.X. Wang, M. Qiu, C. Deng, R. Cheng*, and Z.Y. Zhong*, Targeted and Reduction-Sensitive Crosslinked PLGA Nanotherapeutics for Safer and Enhanced Chemotherapy of Malignant Melanoma, ACS Biomater. Sci. Eng. 2020, 6, 2621-2629.187.pdf

186.S. Li, M. Qiu, J.K. Guo, Z.Y. Zhong*, and C. Deng*, Coating-Sheddable CD44-Targeted PLGA Nanomedicines Fabricated Using Photo-Click-Crosslinkable Hyaluronic Acid-graft-Tetrazole Conjugate as a Surfactant, Adv. Therapeutics 2020, 3, 1900160.186.pdf

185Y. Zou, Y.P. Sun, Y.H. Wei, Y.F. Xia, Z.Y. Huangfu, F.H. Meng*, J. van Hest, and Z.Y. Zhong*,Alfa3beta1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutics for Non-Small Cell Lung Cancer Treatment, ACS Appl. Mater. Interfaces 2020, 12 , 14905-14913.185.pdf

184Y.W. Li, J.J. Wei, Y.H. Wei, L. Cheng*, B.B. Guo, F.H. Meng*, F. Li, and Z.Y. Zhong*, Apolipoprotein E Peptide-Guided Disulfide-Crosslinked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma,Biomacromolecules 2020, 21, 716-724.184.pdf

183H.M. Fang, X.F. Zhao, X.L. Gu, H.L. Sun, R. Cheng, Z.Y. Zhong*, and C. Deng*, CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors in Vivo, Biomacromolecules 2020, 21, 104-113.183.pdf

182Y.H. Wei, F.H. Meng*, G. Storm, and Z.Y. Zhong*, Transferrin-Binding Peptide Functionalized Polymersomes Mediate Targeted Doxorubicin Delivery to Colorectal Cancer In Vivo, J. Control. Release 2020, 319, 407-415.182.pdf

181.Y.N. Zhong, F.H. Meng*, W. Zhang, B. Li, J. van Hest, and Z.Y. Zhong*, CD44-Targeted Vesicles Encapsulating Granzyme B as Artificial Killer Cells for Potent Inhibition of Human Multiple Myeloma in Mice, J. Control. Release 2020, 320, 421-430.181.pdf